A common CTLA4 haplotype associated with coeliac disease.

PubWeight™: 1.65‹?› | Rank: Top 3%

🔗 View Article (PMID 15657618)

Published in Eur J Hum Genet on April 01, 2005

Authors

Karen A Hunt1, Dermot P B McGovern, Parveen J Kumar, Subrata Ghosh, Simon P L Travis, Julian R F Walters, Derek P Jewell, Raymond J Playford, David A van Heel

Author Affiliations

1: Department of Gastroenterology, Imperial College London, Du Cane Road, London W12 0NN, UK.

Articles citing this

A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet (2007) 8.50

Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99

Celiac disease and autoimmune thyroid disease. Clin Med Res (2007) 1.42

Genes and Sjögren's syndrome. Rheum Dis Clin North Am (2008) 1.01

Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer (2007) 0.97

Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut (2006) 0.88

Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms. J Negat Results Biomed (2008) 0.83

Celiac disease and HLA in a Bedouin kindred. Hum Immunol (2006) 0.82

Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians. Clin Vaccine Immunol (2010) 0.80

Antithyroid antibodies and thyroid function in pediatric patients with celiac disease. Int J Endocrinol (2015) 0.79

Celiac autoimmunity in autoimmune thyroid disease is highly prevalent with a questionable impact. Indian J Endocrinol Metab (2016) 0.76

Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn's disease patients. Int J Colorectal Dis (2011) 0.76

Increased Incidence of Thyroid Disease in Patients with Celiac Disease: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75

Association of the CTLA4 gene CT60/rs3087243 single-nucleotide polymorphisms with Graves' disease. Biomed Rep (2015) 0.75

The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease. Biomed Res Int (2014) 0.75

Articles by these authors

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38

Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet (2007) 13.74

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62

Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27

Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16

A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet (2007) 8.50

Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med (2008) 7.66

Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet (2008) 7.63

Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90

Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet (2011) 6.36

Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med (2012) 5.80

Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet (2011) 5.58

Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science (2012) 5.34

Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet (2008) 4.96

Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut (2011) 4.79

Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet (2009) 4.61

Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet (2011) 4.42

Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med (2012) 4.41

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut (2012) 4.24

The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology (2002) 4.20

Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology (2014) 3.77

Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet (2009) 3.65

Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet (2011) 3.65

Genome-wide analysis of allelic expression imbalance in human primary cells by high-throughput transcriptome resequencing. Hum Mol Genet (2010) 3.50

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med (2003) 3.49

Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet (2008) 3.11

Mucosal healing in inflammatory bowel diseases: a systematic review. Gut (2012) 3.02

Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol (2009) 2.99

Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet (2005) 2.93

Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet (2007) 2.89

Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet (2013) 2.85

Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Gut (2010) 2.82

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med (2011) 2.74

Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med (2011) 2.41

Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology (2008) 2.17

Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet (2009) 2.15

Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol (2007) 2.14

The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysis. Inflamm Bowel Dis (2013) 2.05

Opposing effects of smoking in ulcerative colitis and Crohn's disease may be explained by differential effects on dendritic cells. Inflamm Bowel Dis (2014) 2.03

Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med (2010) 1.90

Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int (2008) 1.88

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut (2012) 1.84

NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis (2010) 1.84

Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet (2005) 1.81

Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature (2013) 1.79

Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology (2013) 1.79

Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet (2002) 1.76

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol (2010) 1.74

TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology (2006) 1.73

Inflammatory bowel disease: a Canadian burden of illness review. Can J Gastroenterol (2012) 1.73

Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet (2010) 1.71

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70

Weight loss at high altitude: pathophysiology and practical implications. Eur J Gastroenterol Hepatol (2006) 1.68

Surgeon and patient radiation exposure in minimally invasive transforaminal lumbar interbody fusion. J Neurosurg Spine (2008) 1.67

Gender differences in healthcare-seeking during common illnesses in a rural community of West Bengal, India. J Health Popul Nutr (2002) 1.64

Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS One (2008) 1.64

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation. Trials (2007) 1.62

Recent advances in coeliac disease genetics. Gut (2009) 1.62

Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet (2003) 1.57

A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet (2011) 1.54

A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52

Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. Inflamm Bowel Dis (2007) 1.47

A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity (2007) 1.46

Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease. Eur J Immunol (2006) 1.43

Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur J Immunol (2005) 1.37

Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology (2004) 1.36

Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet (2013) 1.34

Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology (2009) 1.32

Hepatosplenic T cell lymphoma in inflammatory bowel disease. Gut (2008) 1.32

Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis (2010) 1.31

Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nat Genet (2011) 1.30

Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology (2006) 1.29

Indeterminate colitis: a review of the concept--what's in a name? Inflamm Bowel Dis (2008) 1.28

Obstructing giant post-inflammatory polyposis in ulcerative colitis: Case report and review of the literature. J Crohns Colitis (2008) 1.28

Detection, imputation, and association analysis of small deletions and null alleles on oligonucleotide arrays. Am J Hum Genet (2008) 1.27

Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol (2009) 1.27

Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology (2002) 1.26

Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis (2013) 1.25

Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis (2010) 1.25

Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol (2011) 1.24

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology (2002) 1.21

Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun (2006) 1.21

Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus. J Crohns Colitis (2012) 1.21

Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1. J Hepatol (2004) 1.20

The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol (2010) 1.19